20.03.2023 - ACTON, Mass., March 20, 2023 (GLOBE NEWSWIRE) - Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing rapid tests using whole blood on its Symphony platform to improve patient outcomes in .
/PRNewswire/ Statement attributable to: Shannon Haymond, PhD President, American Association for Clinical Chemistry "AACC applauds the decision of the.